Ageing and changes in phosphate transport: Clinical implications

Journal of Nephrology

Volumn 23, Issue SUPPL.16, 2010, Pages

  Cirillo, Massimo ^a   Bilancio, Giancarlo ^a   Marcarelli, Fabiana ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Age; Glomerular filtration rate; Phosphorus; Renal tubule

Indexed keywords

PHOSPHATE;

AGING; ANIMAL; BIOLOGICAL MODEL; FEMALE; HOMEOSTASIS; HUMAN; ION TRANSPORT; KIDNEY; MALE; METABOLISM; PHYSIOLOGY; REVIEW;

AGING; ANIMALS; FEMALE; HOMEOSTASIS; HUMANS; ION TRANSPORT; KIDNEY; MALE; MODELS, BIOLOGICAL; PHOSPHATES;

EID: 79952276824     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD- MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(Suppl 113):S1-S130.
2. Berndt TJ, Kumar R. Clinical disturbances of phosphate homeostasis. In: Alpern RJ, Hebert SC, eds. Seldin and Giebisch's the kidney. 4th ed. Chap. 70. Amsterdam: Elsevier; 2008:1989-2006.
3. Bringhurst FR, Demay MB, Krane SM, Kronenberg HM. Bone and mineral metabolism in health and disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine. 16th ed. Chap. 331. New York: McGraw-Hill; 2005:2238-2249.
4. Yang L, Grey B. Pediatric reference intervals for bone markers. Clin Biochem. 2006;39:561-568.
5. Keating FR Jr, Jones JD, Elveback LR, Randall RV. The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea. J Lab Clin Med. 1969;73:825-834.
6. Yendt ER, Cohanim M, Rosenberg GM. Reduced serum calcium and inorganic phosphate levels in normal elderly women. J Gerontol. 1986;41:325-330.
7. Wiske PS, Epstein S, Bell NH, Queener SF, Edmondson J, Johnston CC Jr. Increases in immunoreactive parathyroid hormone with age. N Engl J Med. 1979;300:1419-1421.
8. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J Clin Endocrinol Metab. 1990;71:405-413.
9. Kotowicz MA, Melton LJ 3rd, Cedel SL, O'Fallon WM, Riggs BL. Effect of age on variables relating to calcium and phosphorus metabolism in women. J Bone Miner Res. 1990;5:345-352.
10. Portale AA, Lonergan ET, Tanney DM, Halloran BP. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men. Am J Physiol. 1997;272:E139-E146.
11. Cirillo M, Ciacci C, De Santo NG. Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults. N Engl J Med. 2008;359:864-866.
12. Ahmad AM, Thomas J, Clewes A, et al. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab. 2003;88:2860-2868.
13. Brabant G, von zur Mühlen A, Wüster C, et al; German KIMS Board. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res. 2003;60:53-60.
14. Uemura H, Irahara M, Yoneda N, et al. Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab. 2000;85:1215-1219.
15. Cobum JW, Kappel MH, Brickman AS, Massry SG. Study of intestinal absorption of calcium in patients with renal failure. Kidney Int. 1973;3:264-272.
16. Madsen S, Olgaard K, Ladefoged J. Renal handling of phosphate in relation to serum parathyroid hormone levels. Acta Med Scand. 1976;200:7-10.
17. Tougaard L, Sorensen E, Christensen MS, Brochner-Mortensen J, Rodbro P, Sorensen AW. Bone composition and parathyroid function in chronic renal failure. Acta Med Scand. 1977;202:33-38.
18. Von Lilienfeld-Toal H, Gerlach I, Klehr HU, Issa S, Keck E. Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron. 1982;31:116-122.
19. Cheung AK, Manolagas SC, Catherwood BD, et al. Determinants of serum 1,25(OH)2D levels in renal disease. Kidney Int. 1983;24:104-109.
20. Pitts TO, Piraino BH, Mitro R, et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988;67:876-881.
21. Coen G, Mazzaferro S, Costantini S, et al. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. Miner Electrolyte Metab. 1989;15:295-302.
22. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant. 1991;6:162-169.
23. St John A, Thomas MB, Davies CP, et al. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron. 1992;61:422-427.
24. Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol. 1994;41:290-296.
25. Fajtova VT, Sayegh MH, Hickey N, Aliabadi P, Lazarus JM, LeBoff MS. Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int. 1995;57:329-335.
26. Messa P, Mioni G, Turrin D, Guerra UP. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Nephrol Dial Tranplant. 1995;10:2259-2265.
27. Yumita S, Suzuki M, Akiba T, Akizawa T, Seino Y, Kurokawa K. Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure. Tohoku J Exp Med. 1996;180:45-56.
28. Martinez I, Saracco R, Montenegro J, Llach F. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patient with early renal failure. Am J Kidney Dis. 1997;29:496-502.
29. Kates DM, Sherrard DJ, Andress DL. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. Am J Kidney Dis. 1997;30:809-813.
30. Rix M, Andreassen H, Eskildsen P, Langdahl B, Olgaard K. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int. 1999;56:1084-1093.
31. Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor- 23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16:2205-2215.
32. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16:520-528.
33. Onufrak SJ, Bellasi A, Shaw LJ, et al. Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis. 2008;199:424-431.
34. Cirillo M, Botta G, Chiricone D, De Santo NG. Glomerular filtration rate and serum phosphate: an inverse relationship diluted by age. Nephrol Dial Transplant. 2009;24:2123-2131.
35. Moranne O, Froissart M, Rossert J, et al; NephroTest Study Group. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20:164-171.